Robert W. Baird Lowers Larimar Therapeutics (NASDAQ:LRMR) Price Target to $10.00
Larimar Therapeutics (NASDAQ:LRMR – Free Report) had its price target reduced by Robert W. Baird from $13.00 to $10.00 in a report issued on Tuesday,Benzinga reports. They currently have an outperform rating on the stock. Several other analysts have also issued reports on LRMR. Truist Financial initiated coverage on shares of Larimar Therapeutics in a […]
Larimar Therapeutics (NASDAQ:LRMR – Free Report) had its price target reduced by Robert W. Baird from $13.00 to $10.00 in a report issued on Tuesday,Benzinga reports. They currently have an outperform rating on the stock. Several other analysts have also issued reports on LRMR. Truist Financial initiated coverage on shares of Larimar Therapeutics in a […]
